(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

AVANTI POLAR LIPIDS, INC.

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: MistaEscritório: US

Snapshot rápido

AVANTI POLAR LIPIDS, INC.

ST13

US500000088632780

Classe

1, 5, 40, 42

Pedido

88632780

Registro

7854388

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

45

Atualização mais recente

01/08/2025

Classificação

Registrada

Tipo de marca

Mista

Classes Nice

1, 5, 40, 42

Data de depósito

26/09/2019

Data de registro

08/07/2025

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

08/07/2025

Última transação

01/08/2025

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Primeiro uso

01/05/2001

Primeiro uso no comércio

01/05/2001

Código do desenho

3

Tipo de titular

16

Localização do titular

ALABASTER, AL

Examinador

PERKINS, ELLEN

Localização atual

FILE REPOSITORY (FRANCONIA)

Descrição da marca

The mark consists of the word "AVANTI" in a stylized font above the words "POLAR LIPIDS, INC." also in stylized font. The wording appears to the right of the design of a stylized liposome.

Titulares e representantes

Titulares

AVANTI POLAR LIPIDS, LLC
Avanti Polar Lipids, Inc.

Representantes

Patrick J. Jennings Pillsbury Winthrop Shaw Pittman, LLP

Classificação técnica

Classes Nice

Classe 1Classe 5Classe 40Classe 42

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 1

Chemical compounds for scientific or research use; adjuvants for scientific or research use; chemical reagents for the delivery of lipids for scientific or research use; chemical compounds for use as standards for use with analytical techniquesmass spectrometry; compounds for scientific or research uselipidssynthetic lipidspolymer modified lipidslipids with modified head groupslipids with modified acyl chainsbioactive lipidsfluorescent lipidsisotope labeled lipidsoxidized lipidssphingolipidslipid extracts from natural sourceslipids conjugated with modified gold particles; compounds for scientific or research usefatty acidsglycerolipidsglycerophospholipidssphingolipidssaccharolipidssterol lipidsprenol lipidslipid preparations suitable for protein crystallizationlipid preparations suitable for protein solubilizationdetergentsamphiphilic detergentsantibodies; diagnostic reagents and analytical reagents for scientific or research use; formulations comprising lipids for scientific or research use; enzymes for scientific or research use; lipidschemical additivesexcipients for use in the manufacture of pharmaceutical preparations

Classe 5

Adjuvants for medical use; immunostimulatory compoundslipids for medical use; medical diagnostic reagents; test strips for the detection of bacterial infections for medical use; isotopes for medical use

Classe 40

cGMP custom manufacture of active agentsadditivesexcipients for others; cGMP custom manufacture of lipids for others; custom manufacturing services for others in the field of active agentsadditivesexcipients in pharmaceutical preparations; custom manufacturing services for others in the field of lipids; providing information relating to the custom manufacture of lipids and chemical compounds for scientific and medical research purposes

Classe 42

Analytical servicesperforming nutraceutical testingNMR analysismass spectrometry analysisinfrared spectroscopy analysischromatography analysisgas chromatography analysisparticle size analysiszeta potential analysisthin layer chromatography analysiswater content analysisperoxide oxidation and phosphorous content analysischemical stability testingdevelopment of chemical analytical methods; scientific research and medical research services; analytical servicesperforming nutraceutical testingNMR analysismass spectrometry analysisinfrared spectroscopy analysischromatography analysisgas chromatography analysisparticle size analysiszeta potential analysisthin layer chromatography analysiswater content analysisperoxide oxidation and phosphorous content analysischemical stability testingdevelopment of chemical analytical methods in the field of lipidsnutraceuticalsfood productspharmaceutical productsdrug development and commercialization; scientific research and product development and consultation related thereto in the field of pharmaceuticals and chemicals; scientific research services for others; scientific research services for others in the field of lipidsnutraceuticalsfood productspharmaceutical productsdrug development and commercialization; lipidomics servicesidentification and quantification of lipid compounds in a sampleidentification of protein-lipid interactionsidentifying the role of lipids in cellular signaling all in the nature of scientific research; cGMP testing serviceslipid raw material release testingdeveloping of testing specifications and standard operating proceduresquality assurance reviewproduct testingchemical stability testing all in the field of pharmaceuticalslipids and chemicals; formulation servicesdevelopment of standards for liposome and nanoparticle formulationsscaling-up manufacturing processestesting and development of standards for synthesis of lipid compounds for use in formulationsin the field of pharmaceuticalslipidschemicals; providing information relating to chemical characterizationanalysis methodsuses of lipids and related compounds for scientific and medical research purpose

Publicações

Histórico de despachos e eventos da marca no USPTO.

45 publicações encontradas

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

08/07/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

08/07/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

20/05/2025

PUBO

PUBLISHED FOR OPPOSITION

20/05/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

14/05/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

22/04/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

17/04/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

17/04/2025

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

17/04/2025

RDX3

NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED

11/04/2025

RDX1

ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED

11/04/2025

RRDX

ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED

11/04/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/03/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/03/2025

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

04/03/2025

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

14/02/2025

GNFR

FINAL REFUSAL E-MAILED

14/02/2025

CNFR

FINAL REFUSAL WRITTEN

14/02/2025

RCCK

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

02/02/2024

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

29/01/2024

RCCK

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

29/12/2023

RCCK

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

02/06/2023

RCSC

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

07/11/2022

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

24/08/2022

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

24/08/2022

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

24/08/2022

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

24/08/2022

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

24/08/2022

RCSC

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

21/03/2022

RCSC

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

20/09/2021

RCSC

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

25/02/2021

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

04/11/2020

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

29/07/2020

GNSL

LETTER OF SUSPENSION E-MAILED

29/07/2020

CNSL

SUSPENSION LETTER WRITTEN

29/07/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

08/07/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

07/07/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

07/07/2020

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

08/01/2020

GNRT

NON-FINAL ACTION E-MAILED

08/01/2020

CNRT

NON-FINAL ACTION WRITTEN

08/01/2020

DOCK

ASSIGNED TO EXAMINER

30/12/2019

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

03/10/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

02/10/2019

NWAP

NEW APPLICATION ENTERED

30/09/2019

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace AVANTI POLAR LIPIDS, INC. ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.